Utility of neuECG to predict the occurrence and recurrence of atrial fibrillation after catheter ablation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037245

Enrollment

Unknown

Registered

2020-08-27

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

autonomic dependent and independent atrial fibrillation:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Paroxysmal atrial fibrillation; 2. Aged between 18 and 90 years; 3. sign the consent.

Exclusion criteria

Exclusion criteria: 1. Severe skin rupture or infection; 2. allergic to patch of neuECG; 3. not willing to receive catheter ablation of atrial firbillation.

Design outcomes

Primary

Measure	Time frame
recurrence of atrial fibrillation;	—

Secondary

Measure	Time frame
sympathetic nerve activities;	—

Countries

China

Contacts

Public ContactJian Sun

Xinhua Hospital, Shanghai Jiao Tong University, School of Medicine

sunjian@xinhuamed.com.cn+86 15801816064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026